Collectively, the evidence supports that hyperactive PI3Kδ/mTOR signaling along with altered programmed cell death contributes to lymphoproliferation and expansion of CD4−/CD8− DNTs in patients with ALPS-FAS (3, 5). Here, MTOR is linked to autoimmune lymphoproliferative syndrome.